Mid-cap Health Care company Baxter International has logged a -1.5% change today on a trading volume of 744,557. The average volume for the stock is 7,247,626.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. Based in Deerfield, United States the company has 38,000 full time employees and a market cap of $9,659,109,376. Baxter International currently offers its equity investors a dividend that yields 3.6% per year.
The company is now trading -21.93% away from its average analyst target price of $24.07 per share. The 15 analysts following the stock have set target prices ranging from $19.0 to $42.0, and on average give Baxter International a rating of hold.
Over the last 12 months BAX shares have declined by -42.4%, which represents a difference of -55.0% when compared to the S&P 500. The stock's 52 week high is $37.74 per share and its 52 week low is $17.4. With its net margins declining an average -18.7% over the last 6 years, Baxter International declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 10,636,000 | -649,000 | -6 | -123.08 |
| 2023 | 10,360,000 | 2,656,000 | 26 | 208.33 |
| 2022 | 10,057,000 | -2,433,000 | -24 | -318.18 |
| 2021 | 12,146,000 | 1,284,000 | 11 | 22.22 |
| 2020 | 11,673,000 | 1,102,000 | 9 | 0.0 |
| 2019 | 11,362,000 | 1,001,000 | 9 |
